SUN PHARMACEUTICAL INDUSTRIES LIMITED

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Efficacy and Safety Study of SUNPG1623

First Posted Date
2016-12-02
Last Posted Date
2023-01-27
Lead Sponsor
Sun Pharmaceutical Industries Limited
Target Recruit Count
391
Registration Number
NCT02980692
Locations
🇺🇸

SPARC Site 1, Middleburg Heights, Ohio, United States

Efficacy and Safety Study of SUNPG1622

First Posted Date
2016-12-02
Last Posted Date
2021-11-01
Lead Sponsor
Sun Pharmaceutical Industries Limited
Target Recruit Count
180
Registration Number
NCT02980705
Locations
🇵🇱

SPARC site 3, ElblÄ…g, Poland

🇺🇸

SPARC Site 1, Middleburg Heights, Ohio, United States

🇪🇸

SPARC site 2, A Coruña, Spain

An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca

Phase 3
Completed
Conditions
Interventions
First Posted Date
2016-07-27
Last Posted Date
2021-11-19
Lead Sponsor
Sun Pharmaceutical Industries Limited
Target Recruit Count
258
Registration Number
NCT02845674

A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer

First Posted Date
2016-04-13
Last Posted Date
2021-11-22
Lead Sponsor
Sun Pharmaceutical Industries Limited
Target Recruit Count
53
Registration Number
NCT02737332
Locations
🇺🇸

North Idaho Urology, Coeur d'Alene, Idaho, United States

🇺🇸

Chesapeake Urology Research Associates, Towson, Maryland, United States

🇺🇸

Lincoln Urology, PC, Lincoln, Nebraska, United States

and more 14 locations

Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca

First Posted Date
2016-02-23
Last Posted Date
2022-08-29
Lead Sponsor
Sun Pharmaceutical Industries Limited
Target Recruit Count
745
Registration Number
NCT02688556
Locations
🇺🇸

Martel Eye Medical Group, Rancho Cordova, California, United States

🇺🇸

Fifth Avenue Eye Associates, New York, New York, United States

🇺🇸

Cincinnati Eye Institute, Edgewood, Kentucky, United States

To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis

First Posted Date
2015-08-28
Last Posted Date
2021-11-19
Lead Sponsor
Sun Pharmaceutical Industries Limited
Target Recruit Count
150
Registration Number
NCT02534896
Locations
🇧🇪

Sun Pharma Site 23, Brussels, Belgium

🇧🇪

Sun Pharma Site 20, Merksem, Belgium

🇧🇪

Sun Pharma Site 16, Leuven, Belgium

and more 17 locations

ABSORICA in Patients With Severe Recalcitrant Nodular Acne

Phase 4
Completed
Conditions
Interventions
First Posted Date
2015-05-29
Last Posted Date
2021-04-27
Lead Sponsor
Sun Pharmaceutical Industries Limited
Target Recruit Count
201
Registration Number
NCT02457520
Locations
🇺🇸

Texas Dermatology and Laser Specialists, San Antonio, Texas, United States

Bio-equivalence Study Between SAPHRIS and Asenapine

Phase 1
Completed
Conditions
Interventions
First Posted Date
2013-09-23
Last Posted Date
2021-04-30
Lead Sponsor
Sun Pharmaceutical Industries Limited
Target Recruit Count
65
Registration Number
NCT01948024
Locations
🇺🇸

Woodland International Research Group, Inc., Little Rock, Arkansas, United States

🇺🇸

Collaborative Neuroscience Network, LLC, Garden Grove, California, United States

🇺🇸

Clinical Innovations, Inc, Costa Mesa, California, United States

and more 4 locations
© Copyright 2024. All Rights Reserved by MedPath